1. Home
  2. JDZG vs AYTU Comparison

JDZG vs AYTU Comparison

Compare JDZG & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JDZG

JIADE LIMITED

HOLD

Current Price

$0.12

Market Cap

27.3M

Sector

Real Estate

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.54

Market Cap

25.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JDZG
AYTU
Founded
2020
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.3M
25.7M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
JDZG
AYTU
Price
$0.12
$2.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
9.2M
42.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,632,080.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$44.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
277.47
52 Week Low
$0.11
$0.95
52 Week High
$4.06
$3.07

Technical Indicators

Market Signals
Indicator
JDZG
AYTU
Relative Strength Index (RSI) 39.07 54.76
Support Level N/A $2.14
Resistance Level $0.57 $2.65
Average True Range (ATR) 0.20 0.13
MACD -0.04 0.04
Stochastic Oscillator 0.66 71.30

Price Performance

Historical Comparison
JDZG
AYTU

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: